Pfizer Inc., of New York, said it launched a competitive grants program it is funding to support research projects investigating the role of proprotein convertase subtilisin kexin type 9 (PCSK9) in health and cardiovascular disease. Read More
Geovax Labs Inc., of Atlanta, presented preclinical and clinical data from its preventive HIV vaccine candidate, GOVX-B11, at the World Vaccine Congress in Washington. Read More
Cardiome Pharma Corp., of Vancouver, British Columbia, disclosed reimbursement approval for Brinavess (vernakalant) by Belgium's national compulsory health care and benefits insurance authority. Read More
Conatus Pharmaceuticals Inc., of San Diego, completed its underwritten public offering of 4.025 million common shares at $5.75 apiece, including 525,000 shares sold as the full exercise of the overallotment option, for net proceeds of approximately $21.4 million. Read More
Reports of a myeloma patient and her family being kicked off an airplane this week highlight some of the problems with turning patient-expressed needs into science-based assessments that can be used to measure endpoints in clinical trials for new drugs and devices. Read More
Using cancer cells with a molecular barcode, scientists have gained new insights into how tumors form blood vessel-like structures to feed themselves – a process known as molecular mimicry – and how they then use those structures to slip into the general circulation and seed distant metastases. Read More
The prospect of establishing a specially focused orphan drug megafund, through which investors put money down and collect on the spoils as drugs and intellectual property rights are sold to venture capitalists or pharma firms, is one due to be explored during a panel talk at the Allicense 2015 conference by Andrew Lo, Sloan professor of finance at the Massachusetts Institute of Technology (MIT). Read More
Lead candidate EG-1962, a polymer-based microparticle formulation of the FDA-approved calcium channel inhibitor nimodipine, more than piqued the curiosity of investors, who plowed approximately $72.5 million into Edge Therapeutics Inc. in two follow-on C rounds. Read More
The FDA will expand the delivery of its Consumer Updates about drugs and other regulated products through a new partnership with Healthline.com. Read More
